| Primary |
| Drug Use For Unknown Indication |
50.9% |
| Product Used For Unknown Indication |
16.9% |
| Nasopharyngitis |
4.4% |
| Pharyngitis |
4.2% |
| Pyrexia |
3.9% |
| Infection |
3.7% |
| Upper Respiratory Tract Inflammation |
3.5% |
| Acute Myocardial Infarction |
2.1% |
| Drug Exposure During Pregnancy |
2.0% |
| Infection Prophylaxis |
1.2% |
| Acute Tonsillitis |
0.9% |
| Inflammation |
0.9% |
| Wound Abscess |
0.9% |
| Gastroenteritis |
0.8% |
| Neck Pain |
0.8% |
| Influenza |
0.7% |
| Tonsillitis |
0.7% |
| Gastritis |
0.6% |
| Urinary Tract Infection |
0.6% |
| Anticoagulant Therapy |
0.5% |
|
| Pyrexia |
15.3% |
| Stevens-johnson Syndrome |
12.7% |
| Toxic Epidermal Necrolysis |
10.2% |
| Liver Disorder |
6.8% |
| Hepatic Function Abnormal |
5.9% |
| Ulcerative Keratitis |
5.9% |
| Wheezing |
5.1% |
| Oesophageal Atresia |
3.4% |
| Rash |
3.4% |
| Thirst |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Tubulointerstitial Nephritis |
3.4% |
| Urinary Retention |
3.4% |
| Convulsion |
2.5% |
| Cystitis Haemorrhagic |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
| Nephritis |
2.5% |
| Purpura |
2.5% |
| Sepsis |
2.5% |
| Skin Exfoliation |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
39.7% |
| Product Used For Unknown Indication |
11.7% |
| Pyrexia |
6.4% |
| Upper Respiratory Tract Inflammation |
4.8% |
| Infection Prophylaxis |
4.3% |
| Pneumonia |
3.8% |
| Osteoporosis |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Dyspepsia |
2.6% |
| Glaucoma |
2.6% |
| Nasopharyngitis |
2.6% |
| Inflammation |
2.1% |
| Contusion |
1.9% |
| Parkinson's Disease |
1.9% |
| Spinal Osteoarthritis |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Wound Abscess |
1.8% |
| Kawasaki's Disease |
1.6% |
| Urinary Tract Infection |
1.6% |
| Cataract Operation |
1.3% |
|
| Toxic Epidermal Necrolysis |
17.9% |
| Pyrexia |
9.5% |
| Drug Exposure During Pregnancy |
6.0% |
| Rash |
6.0% |
| Spinal Compression Fracture |
6.0% |
| White Blood Cell Count Decreased |
6.0% |
| Agranulocytosis |
4.8% |
| Anosmia |
4.8% |
| Unevaluable Event |
4.8% |
| Vulval Disorder |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Liver Disorder |
3.6% |
| Nephrotic Syndrome |
3.6% |
| Purpura |
3.6% |
| Interstitial Lung Disease |
2.4% |
| Platelet Count Decreased |
2.4% |
| Rash Pruritic |
2.4% |
| Renal Impairment |
2.4% |
| Rhinorrhoea |
2.4% |
| Sudden Death |
2.4% |
|
| Concomitant |
| Hypertension |
15.2% |
| Drug Use For Unknown Indication |
12.6% |
| Product Used For Unknown Indication |
8.5% |
| Prophylaxis |
6.2% |
| Influenza |
4.9% |
| Nasopharyngitis |
4.6% |
| Rheumatoid Arthritis |
4.5% |
| Insomnia |
4.2% |
| Constipation |
3.9% |
| Infection Prophylaxis |
3.8% |
| Back Pain |
3.7% |
| Breast Cancer |
3.7% |
| Eczema |
3.4% |
| Herpes Zoster |
3.3% |
| Upper Respiratory Tract Inflammation |
3.3% |
| Diabetes Mellitus |
3.1% |
| Pain |
3.1% |
| Infection |
2.8% |
| Bronchitis |
2.7% |
| Pneumonia |
2.6% |
|
| Drug Exposure During Pregnancy |
13.7% |
| Vomiting |
10.5% |
| White Blood Cell Count Decreased |
7.4% |
| Loss Of Consciousness |
6.3% |
| Abnormal Behaviour |
5.3% |
| Pneumonia |
5.3% |
| White Blood Cell Count Increased |
5.3% |
| Hypoaesthesia |
4.2% |
| Muscle Spasms |
4.2% |
| Renal Failure Acute |
4.2% |
| Upper Respiratory Tract Inflammation |
4.2% |
| Yawning |
4.2% |
| Cryptogenic Organising Pneumonia |
3.2% |
| Peritonitis |
3.2% |
| Post Procedural Haemorrhage |
3.2% |
| Pyrexia |
3.2% |
| Rash |
3.2% |
| Shock |
3.2% |
| Somnolence |
3.2% |
| Staphylococcal Infection |
3.2% |
|
